首页> 美国卫生研究院文献>Journal of Clinical Microbiology >Feasibility of Detecting Human Immunodeficiency Virus Type 1 Drug Resistance in DNA Extracted from Whole Blood or Dried Blood Spots
【2h】

Feasibility of Detecting Human Immunodeficiency Virus Type 1 Drug Resistance in DNA Extracted from Whole Blood or Dried Blood Spots

机译:从全血或干血斑提取的DNA中检测人类免疫缺陷病毒1型耐药的可行性

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。

摘要

Due to high cost, availability of human immunodeficiency virus type 1 (HIV-1) drug resistance testing in resource-poor settings is still limited. We therefore evaluated the usefulness of viral DNA extracted from either whole blood or dried blood spots (DBS). Samples were collected from 50 patients receiving therapy and 10 therapy-naïve patients. Amplification and sequencing of RNA and DNA was performed using an in-house assay. Protease (PR) and reverse transcriptase (RT) sequences of plasma viral RNA were obtained for 96.6% and 89.7%, respectively, of the 29 patients with a detectable viral load. For cellular viral DNA, useful PR and RT sequences were obtained for 96.6% and 93.1% of the whole-blood-cell samples and for 93.1% and 93.1% of the DBS samples, respectively. For the 31 patients with an undetectable viral load, PR and RT sequences were obtained for 67.7% and 61.3% of the whole-blood-cell DNA preparations and for 54.8% and 58.1% of the DBS DNA preparations, respectively. A good correlation between RNA and DNA sequences was found; most discordances were caused by the detection of mixed amino acids. Of the RT drug-resistant mutations, 13 (38.2%) were seen in RNA only, 6 (17.6%) in DNA only, and 15 (44.1%) in both. Repeated amplification and sequencing of DNA extracts revealed a lack of reproducibility for the detection of drug resistance mutations in a number of samples, indicating a possible founder effect. In conclusion, this study shows the feasibility of genotypic drug resistance testing on whole blood cells or DBS and its possible usefulness for HIV-1 subtyping or examining the overall distribution of drug resistance in a population. For individual patients, RNA sequencing was shown to be superior to DNA sequencing, especially for patients who experienced early treatment failure. The use of DNA extracted from whole blood or DBS for the detection of archived drug resistance mutations deserves further study.
机译:由于成本高昂,在资源贫乏地区,人类1型免疫缺陷病毒(HIV-1)耐药性检测的可用性仍然受到限制。因此,我们评估了从全血或干血斑(DBS)提取的病毒DNA的有用性。从50名接受治疗的患者和10名未接受过治疗的患者中收集样本。 RNA和DNA的扩增和测序使用内部分析进行。在29名病毒载量可检测的患者中,血浆病毒RNA的蛋白酶(PR)和逆转录酶(RT)序列分别获得了96.6%和89.7%。对于细胞病毒DNA,分别获得了96.6%和93.1%的全血样品以及93.1%和93.1%的DBS样品有用的PR和RT序列。对于31名病毒载量无法检测的患者,分别获得了67.7%和61.3%的全血DNA制剂以及54.8%和58.1%的DBS DNA制剂的PR和RT序列。发现RNA和DNA序列之间有良好的相关性。大多数不一致之处是由混合氨基酸的检测引起的。在RT耐药性突变中,仅在RNA中发现13个(38.2%),仅在DNA中发现6个(17.6%),在两者中均发现15个(44.1%)。 DNA提取物的重复扩增和测序表明,在许多样品中检测耐药性突变均缺乏可重复性,这表明可能存在创始人效应。总之,这项研究显示了对全血细胞或DBS进行基因型耐药性测试的可行性,以及其对HIV-1亚型或检查人群总体耐药性的可能有用性。对于个别患者,RNA测序显示出优于DNA测序,特别是对于那些经历早期治疗失败的患者。从全血或DBS中提取的DNA用于检测已存档的耐药性突变值得进一步研究。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号